Trader consensus heavily favors a trilogy bout with bantamweight champion Petr Yan against Merab Dvalishvili at 69%, driven by their 1-1 rivalry—Dvalishvili's 2023 win followed by Yan's unanimous decision title recapture at UFC 323 in December 2025—and Yan's January statements confirming a promised immediate rematch regardless of other results. Yan's back surgery recovery progresses on track for full training in April, targeting a summer defense like International Fight Week, while Dvalishvili insists on waiting despite a broken nose from a non-training accident on April 2 that briefly dipped odds. Sean O'Malley trails at 11.4% as a stylistic stylistic matchup and former champ advocating alternatives, with rising contenders like Umar Nurmagomedov at 5.5% reflecting divisional depth but low volume absent official matchmaking. Recent injury updates underscore uncertainty in exact timing, yet the trilogy's momentum dominates skin-in-the-game pricing.
Experimental AI-generated summary referencing Polymarket data · UpdatedMerab Dvalishvili 68%
Sean O’Malley 11.4%
Umar Nurmagomedov 5.5%
Payton Talbott 1.7%
$191,961 Vol.
$191,961 Vol.
Merab Dvalishvili
68%
Sean O’Malley
11%
Umar Nurmagomedov
6%
Payton Talbott
2%
Alexandre Pantoja
1%
Ricky Simón
1%
Cory Sandhagen
1%
Rob Font
1%
Deiveson Figueiredo
<1%
Alexander Volkanovski
<1%
Song Yadong
<1%
Pedro Munhoz
<1%
Dominick Cruz
<1%
Henry Cejudo
<1%
Merab Dvalishvili 68%
Sean O’Malley 11.4%
Umar Nurmagomedov 5.5%
Payton Talbott 1.7%
$191,961 Vol.
$191,961 Vol.
Merab Dvalishvili
68%
Sean O’Malley
11%
Umar Nurmagomedov
6%
Payton Talbott
2%
Alexandre Pantoja
1%
Ricky Simón
1%
Cory Sandhagen
1%
Rob Font
1%
Deiveson Figueiredo
<1%
Alexander Volkanovski
<1%
Song Yadong
<1%
Pedro Munhoz
<1%
Dominick Cruz
<1%
Henry Cejudo
<1%
Resolution for this market will be based on the next UFC fighter that Petr Yan is officially announced to fight, regardless of whether the fight ends up taking place.
Only official announcements from the UFC, which include a scheduled date for the bout, will count. Announcements with no date or which do not confirm that the fight is official, speculation, or other unofficial announcements will not count.
If Yan is officially announced to fight any non-listed fighter or no qualifying announcement is made by December 31, 2026, 11:59 PM ET, this market will resolve to “Other”.
The primary resolution source for this market will be official information from the UFC (https://www.ufc.com/).
Market Opened: Dec 8, 2025, 5:17 PM ET
Resolver
0x2F5e3684c...Resolution for this market will be based on the next UFC fighter that Petr Yan is officially announced to fight, regardless of whether the fight ends up taking place.
Only official announcements from the UFC, which include a scheduled date for the bout, will count. Announcements with no date or which do not confirm that the fight is official, speculation, or other unofficial announcements will not count.
If Yan is officially announced to fight any non-listed fighter or no qualifying announcement is made by December 31, 2026, 11:59 PM ET, this market will resolve to “Other”.
The primary resolution source for this market will be official information from the UFC (https://www.ufc.com/).
Resolver
0x2F5e3684c...Trader consensus heavily favors a trilogy bout with bantamweight champion Petr Yan against Merab Dvalishvili at 69%, driven by their 1-1 rivalry—Dvalishvili's 2023 win followed by Yan's unanimous decision title recapture at UFC 323 in December 2025—and Yan's January statements confirming a promised immediate rematch regardless of other results. Yan's back surgery recovery progresses on track for full training in April, targeting a summer defense like International Fight Week, while Dvalishvili insists on waiting despite a broken nose from a non-training accident on April 2 that briefly dipped odds. Sean O'Malley trails at 11.4% as a stylistic stylistic matchup and former champ advocating alternatives, with rising contenders like Umar Nurmagomedov at 5.5% reflecting divisional depth but low volume absent official matchmaking. Recent injury updates underscore uncertainty in exact timing, yet the trilogy's momentum dominates skin-in-the-game pricing.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions